Apatinib ameliorates doxorubicin-induced migration and cancer stemness of osteosarcoma cells by inhibiting Sox2 via STAT3 signaling
ConclusionThese results suggested that AP significantly abolished the DOX-induced stemness phenotype and metastasis capacity in osteosarcoma cells by inhibiting Sox2 via STAT3 signalling.
Source: Journal of Orthopaedic Translation - Category: Orthopaedics Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Nanotechnology | Orthopaedics | Osteosarcoma | Study